Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Alkem Laboratories Ltd.
NSE: ALKEM
|
BSE: 539523
|
ISIN: INE540L01014
|
Industry: Pharmaceuticals
|
Mid-range Performer
4899.0000
-132.10
(
-2.63
%)
NSE
Aug 01, 2025
15:31 PM
Volume:
220.6K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Alkem Laboratories Ltd.
26 May 2021
4899.00
-2.63%
Alkem Labs (BUY): Poor US sales and inventory provision affect Q4
Buy:
Alkem Laboratories Ltd.
by
BOB Capital Markets Ltd.
Target: 3620
Target
BOB Capital Markets Ltd.
Alkem Labs reported a below-expected Q4FY21 with +7%/4% YoY sales/EBITDA growth.
Alkem Laboratories Ltd.'s price crossed below 50Day SMA today
More from Alkem Laboratories Ltd.
Recommended
Five Interesting Stocks Today - August 1, 2025
The Baseline |
01 Aug 2025, 05:05PM
Market closes lower, Godrej Properties' revenue beats Forecaster estimates by 40% in Q1
Trendlyne Marketwatch |
01 Aug 2025, 03:57PM
Alkem Laboratories hopes to fire up its US business to fuel future growth
|
02 Jul 2021, 09:50AM